{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-021770","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.415235+00:00","generated_at":"2026-06-28T12:34:34.182631+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ApolloMed Q3 revenue $227.1M (+26% YoY), raises FY guidance; appoints Brandon Sim Co-CEO","bullets":["Q3 revenue $227.1M (+26% YoY); EPS diluted $0.74 (up 64%); net income attributable to ApolloMed $34.3M (up 105%).","FY2021 guidance raised: revenue $751.5-758.5M, net income attributable $71.5-73.5M, adjusted EBITDA $168.5-170.5M.","Brandon Sim appointed Co-CEO effective Nov 2; Kenneth Sim steps down as Co-CEO but remains Executive Chairman."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-021770","json":"https://secwatch.observer/filing/0001628280-21-021770.json","markdown":"https://secwatch.observer/filing/0001628280-21-021770.md","text":"https://secwatch.observer/filing/0001628280-21-021770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000162828021021770/0001628280-21-021770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000162828021021770/ameh-20211104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:34:34.182631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b454e23a4b","claim":"Kenneth Sim changed role as Executive Chairman at Astrana Health, Inc..","evidence_excerpt":"In connection with Brandon Sim’s appointment, Kenneth Sim, M.D. will step out of his current role as Co-Chief Executive Officer. He will continue to serve as the Company’s Executive Chairman.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828021021770/0001628280-21-021770-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"f453df2f86","claim":"Brandon Sim was appointed as Co-Chief Executive Officer at Astrana Health, Inc..","evidence_excerpt":"On November 2, 2021, the Company appointed Brandon Sim as the Company’s Co-Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000162828021021770/0001628280-21-021770-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Co-Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}